close
Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com.
The European Commission has authorized GSK’s HIV-focused unit ViiV Healthcare’s cabotegravir long-acting injectable and tablets, the British drugmaker said on Tuesday.
EUROPEAN COMMISSION CHIEF URSULA VON DER LEYEN ASSURES AID TO FLOOD-STRICKEN SLOVENIA DURING VISIT
Cabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acquired HIV-1 infection in high-risk adults and adolescents weighing at least 77.16 pounds, according to the company.
The GlaxoSmithKline logo is seen in this illustration, Aug. 10, 2022. (REUTERS/Dado Ruvic/Illustration/File Photo)
Sold under brand name Apretude, it is currently approved for use in the United States, Australia, Zimbabwe, South Africa, Malawi, Botswana and Brazil.
CLICK HERE TO GET THE FOX NEWS APP
close Video Pentagon says more than 125 aircraft, 24 tomahawks used in attack against Iran…
close Video ISIS suicide bomber kills 22 at Christian church in Syria, reports The Guardian…
close Video Iran fires back at Israel overnight after US targets nuclear facilities Fox News'…
close Video Israeli pilot, navigator on importance of their missions An Israeli pilot and a…
close Video Expert warns there will be 'hell to pay' if Iran retaliates Capital Research…
close Video Former Israeli prime minister says fight with Iran going ‘incredibly well’ Former Israeli…